Frontlight ResearchEarly access
Graves' disease trials in Sweden
6 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in SwedenA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.
- Where
- Goteborg, Linkoping, Solna
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07596849 · EU 2025-523333-26-00 - Phase 2Not yet taking people in SwedenProphylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)
- Where
- Gothenburg, Lund, Malmö, Örebro, Stockholm, Umeå, Uppsala
- Age
- 18 years to 85 years
- People
- 554
- Run by
- Region Skane
See details and how to joinNCT07883356 · EU 2023-504654-35-00 - Phase 3Taking peoplePreoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
- Where
- Solna
- Age
- 18 years to 75 years
- People
- 182
- Run by
- Jan Calissendorff
See details and how to joinNCT04856488 · EU 2024-517110-15-00 - No phaseTaking peopleCourse for Brain Fatigue After Graves' Disease Controlled Study
- Where
- Gothenburg
- Age
- 18 years to 72 years
- People
- 96
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06134219 - No phaseTaking peopleThe Impact of Person Centred Care (PCC) in Grave's Disease
- Where
- Gothenburg
- Age
- 18 years to 65 years
- People
- 220
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06309316 - Phase 3Taking peopleTreatment of Graves´ophthalmopathy with Simvastatin (GO-S)
- Where
- Malmö
- Age
- 18 years to 70 years
- People
- 80
- Run by
- Lund University
See details and how to joinNCT03131726